Duroziez's disease
Duroziez's disease is a rare medical condition characterized by a specific type of aortic regurgitation. It is named after the French physician Paul Louis Duroziez, who first described the condition in the 19th century. The disease is often associated with a distinctive murmur known as Duroziez's sign, which can be heard over the femoral artery.
Pathophysiology[edit | edit source]
Duroziez's disease involves the improper closure of the aortic valve, leading to the backflow of blood from the aorta into the left ventricle during diastole. This backflow increases the workload on the left ventricle, which can lead to left ventricular hypertrophy and eventually heart failure if left untreated.
Clinical Features[edit | edit source]
The hallmark of Duroziez's disease is the presence of Duroziez's sign, a double murmur heard over the femoral artery when it is compressed. Other symptoms may include:
- Dyspnea (shortness of breath)
- Fatigue
- Palpitations
- Angina (chest pain)
Diagnosis[edit | edit source]
The diagnosis of Duroziez's disease is primarily clinical, based on the presence of Duroziez's sign and other symptoms of aortic regurgitation. Echocardiography is often used to confirm the diagnosis and assess the severity of the regurgitation. Additional diagnostic tools may include:
Treatment[edit | edit source]
The treatment of Duroziez's disease focuses on managing the symptoms and preventing complications. Medical management may include:
- Diuretics to reduce fluid overload
- Vasodilators to decrease the workload on the heart
- Beta-blockers to control heart rate
In severe cases, surgical intervention such as aortic valve replacement may be necessary.
Prognosis[edit | edit source]
The prognosis of Duroziez's disease varies depending on the severity of the aortic regurgitation and the patient's overall health. Early diagnosis and appropriate management are crucial for improving outcomes.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD